{"id":933506,"date":"2026-02-03T07:02:00","date_gmt":"2026-02-03T12:02:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/"},"modified":"2026-02-03T07:02:00","modified_gmt":"2026-02-03T12:02:00","slug":"bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/","title":{"rendered":"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care"},"content":{"rendered":"

<\/p>\n

Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care<\/b><\/p>\n

Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually<\/i><\/b><\/p>\n

Clinician-focused educational program, developed in partnership with Johnson & Johnson, highlights care for patients at high risk of thromboembolic events such as stroke, and the emerging potential of factor XIa (FXIa) research to meet unmet needs<\/i><\/b><\/p>\n

PRINCETON, N.J.–(BUSINESS WIRE<\/a>)–Bristol Myers Squibb<\/a> (NYSE: BMY) announced today the launch of “Change the Target. Change What\u2019s Possible.”<\/i> an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need in cardiovascular care for patients who, despite currently available therapies, remain at high risk of thromboembolic events, underscoring the need for new innovations to help address one of the leading causes of death and disability in the U.S. The unmet need is significant – 40% of patients with atrial fibrillation are untreated or undertreated, and roughly 25% of strokes are recurrent, many of which are considered preventable – with potential bleeding risks contributing to gaps in protection.<\/p>\n

\n\u201cWith heart disease and stroke among the leading causes of death and disability worldwide, it is imperative to continue research in preventing these events,\u201d said Clay Johnston, MD, PhD, MPH, co-founder, chief medical officer, Harbor Health in Austin, Texas. \u201cPatients at risk for stroke and other thromboembolic events really need drugs that reduce the risk of dangerous clots without increasing their bleeding risk, and targeting factor XIa may open this possibility.\u201d<\/p>\n

\nTherapy for thromboembolic diseases has evolved, enabling selective targeting within the coagulation cascade. However, inhibition of coagulation factors within the common pathway can compromise healthy clotting. There remains a need to improve the prevention of thrombosis while preserving the body\u2019s ability to form good clots that help reduce bleeding complications while on an anticoagulant or an antiplatelet agent.<\/p>\n

\n“Despite advances in cardiovascular care, some patients with thromboembolic disease remain at high risk because current therapies may require difficult trade-offs between efficacy and bleeding,\u201d said Tania Small, MD, senior vice president and head of Medical Affairs, Bristol Myers Squibb. \u201cA better understanding of the coagulation cascade has led to the identification of new targets, such as factor XIa, informing how we approach the research of thrombosis prevention while preserving healthy clotting.\u201d<\/p>\n

\nFor more information about \u201cChange the Target. Change What\u2019s Possible.<\/i>\u201d and to learn more about factor XIa inhibition, visit www.factorxi.com<\/a>.<\/p>\n

About<\/b>Factor XIa (FXIa)<\/b><\/p>\n

\nFactor XIa (FXIa) is a promising new target in thromboembolic disease that has the potential to reduce thrombosis without increased bleeding risk.FXIa plays an important role in thrombin generation and clot propagation, which can contribute to thromboembolic events.Inhibition of FXIa may decouple hemostasis (healthy clotting) from thrombosis (formation of harmful clots), potentially preventing formation of dangerous clots without affecting healthy clotting or increasing bleeding risk.<\/p>\n

About<\/b>the Bristol Myers Squibb-Johnson & Johnson Collaboration<\/b><\/p>\n

\nBristol Myers Squibb and Johnson & Johnson, two leaders in cardiovascular care, are determined to close the gap in unmet needs in thrombosis management by overcoming the limits of today\u2019s treatments. The collaboration aims to leverage the combined scientific expertise and world-class commercial capabilities of each company to improve patient outcomes. Bristol Myers Squibb and Johnson & Johnson are investigating factor XIa for the potential treatment of thromboembolic diseases. The Alliance is also proud to support the cardiovascular and neurological community through a variety of partnerships with patient advocacy organizations who serve as key resources to those with cardiovascular and cerebrovascular diseases.<\/p>\n

About Bristol Myers Squibb: Transforming Patients\u2019 Lives Through Science<\/b><\/p>\n

\nAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what\u2019s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com<\/a> or follow us on LinkedIn<\/a>, X<\/a>, YouTube<\/a>, Facebook<\/a> and Instagram<\/a>.<\/p>\n

\ncorporatefinancial-news<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260202178392\/en\/<\/a><\/span><\/p>\n

Bristol Myers Squibb
\n
<\/b>
Media Inquiries:
\n<\/b>
media@bms.com
\n<\/a><\/p>\n

Investors:
\n<\/b>
investor.relations@bms.com<\/a><\/p>\n

KEYWORDS:<\/b> New Jersey United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually Clinician-focused educational program, developed in partnership with Johnson & Johnson, highlights care for patients at high risk of thromboembolic events such as stroke, and the emerging potential of factor XIa (FXIa) research to meet unmet needs PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) announced today the launch of “Change the Target. Change What\u2019s Possible.” an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need … <\/p>\n

Continue reading “Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-933506","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBristol Myers Squibb Introduces "Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bristol Myers Squibb Introduces "Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually Clinician-focused educational program, developed in partnership with Johnson & Johnson, highlights care for patients at high risk of thromboembolic events such as stroke, and the emerging potential of factor XIa (FXIa) research to meet unmet needs PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) announced today the launch of “Change the Target. Change What\u2019s Possible.” an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need … Continue reading "Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-03T12:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care\",\"datePublished\":\"2026-02-03T12:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/\"},\"wordCount\":740,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/\",\"name\":\"Bristol Myers Squibb Introduces \\\"Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-02-03T12:02:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bristol Myers Squibb Introduces \"Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/","og_locale":"en_US","og_type":"article","og_title":"Bristol Myers Squibb Introduces \"Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care - Market Newsdesk","og_description":"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually Clinician-focused educational program, developed in partnership with Johnson & Johnson, highlights care for patients at high risk of thromboembolic events such as stroke, and the emerging potential of factor XIa (FXIa) research to meet unmet needs PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) announced today the launch of “Change the Target. Change What\u2019s Possible.” an educational campaign developed in partnership with Johnson & Johnson for clinicians who manage cardiovascular and thromboembolic conditions. The program spotlights the unmet need … Continue reading \"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-03T12:02:00+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care","datePublished":"2026-02-03T12:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/"},"wordCount":740,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/","name":"Bristol Myers Squibb Introduces \"Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-02-03T12:02:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260202178392r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bristol-myers-squibb-introduces-change-the-target-change-whats-possible-to-highlight-unmet-needs-in-cardiovascular-and-thromboembolic-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bristol Myers Squibb Introduces “Change the Target. Change What\u2019s Possible.\u201d to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/933506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=933506"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/933506\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=933506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=933506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=933506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}